Renal Stenting Coverage Reconsidered: AHRQ Comparative Analysis Effect

CMS' decision last week to reconsider its national coverage policy for renal artery angioplasty and stenting is the agency's first coverage action to grow out of the Effective Health Care Program, the Agency for Healthcare Research & Quality's new comparative effectiveness review arm